Cargando…

The Role of Inhibition in Generating and Controlling Parkinson’s Disease Oscillations in the Basal Ganglia

Movement disorders in Parkinson’s disease (PD) are commonly associated with slow oscillations and increased synchrony of neuronal activity in the basal ganglia. The neural mechanisms underlying this dynamic network dysfunction, however, are only poorly understood. Here, we show that the strength of...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Arvind, Cardanobile, Stefano, Rotter, Stefan, Aertsen, Ad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Research Foundation 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3199726/
https://www.ncbi.nlm.nih.gov/pubmed/22028684
http://dx.doi.org/10.3389/fnsys.2011.00086
_version_ 1782214583774085120
author Kumar, Arvind
Cardanobile, Stefano
Rotter, Stefan
Aertsen, Ad
author_facet Kumar, Arvind
Cardanobile, Stefano
Rotter, Stefan
Aertsen, Ad
author_sort Kumar, Arvind
collection PubMed
description Movement disorders in Parkinson’s disease (PD) are commonly associated with slow oscillations and increased synchrony of neuronal activity in the basal ganglia. The neural mechanisms underlying this dynamic network dysfunction, however, are only poorly understood. Here, we show that the strength of inhibitory inputs from striatum to globus pallidus external (GPe) is a key parameter controlling oscillations in the basal ganglia. Specifically, the increase in striatal activity observed in PD is sufficient to unleash the oscillations in the basal ganglia. This finding allows us to propose a unified explanation for different phenomena: absence of oscillation in the healthy state of the basal ganglia, oscillations in dopamine-depleted state and quenching of oscillations under deep-brain-stimulation (DBS). These novel insights help us to better understand and optimize the function of DBS protocols. Furthermore, studying the model behavior under transient increase of activity of the striatal neurons projecting to the indirect pathway, we are able to account for both motor impairment in PD patients and for reduced response inhibition in DBS implanted patients.
format Online
Article
Text
id pubmed-3199726
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Frontiers Research Foundation
record_format MEDLINE/PubMed
spelling pubmed-31997262011-10-25 The Role of Inhibition in Generating and Controlling Parkinson’s Disease Oscillations in the Basal Ganglia Kumar, Arvind Cardanobile, Stefano Rotter, Stefan Aertsen, Ad Front Syst Neurosci Neuroscience Movement disorders in Parkinson’s disease (PD) are commonly associated with slow oscillations and increased synchrony of neuronal activity in the basal ganglia. The neural mechanisms underlying this dynamic network dysfunction, however, are only poorly understood. Here, we show that the strength of inhibitory inputs from striatum to globus pallidus external (GPe) is a key parameter controlling oscillations in the basal ganglia. Specifically, the increase in striatal activity observed in PD is sufficient to unleash the oscillations in the basal ganglia. This finding allows us to propose a unified explanation for different phenomena: absence of oscillation in the healthy state of the basal ganglia, oscillations in dopamine-depleted state and quenching of oscillations under deep-brain-stimulation (DBS). These novel insights help us to better understand and optimize the function of DBS protocols. Furthermore, studying the model behavior under transient increase of activity of the striatal neurons projecting to the indirect pathway, we are able to account for both motor impairment in PD patients and for reduced response inhibition in DBS implanted patients. Frontiers Research Foundation 2011-10-24 /pmc/articles/PMC3199726/ /pubmed/22028684 http://dx.doi.org/10.3389/fnsys.2011.00086 Text en Copyright © 2011 Kumar, Cardanobile, Rotter and Aertsen. http://www.frontiersin.org/licenseagreement This is an open-access article subject to a non-exclusive license between the authors and Frontiers Media SA, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and other Frontiers conditions are complied with.
spellingShingle Neuroscience
Kumar, Arvind
Cardanobile, Stefano
Rotter, Stefan
Aertsen, Ad
The Role of Inhibition in Generating and Controlling Parkinson’s Disease Oscillations in the Basal Ganglia
title The Role of Inhibition in Generating and Controlling Parkinson’s Disease Oscillations in the Basal Ganglia
title_full The Role of Inhibition in Generating and Controlling Parkinson’s Disease Oscillations in the Basal Ganglia
title_fullStr The Role of Inhibition in Generating and Controlling Parkinson’s Disease Oscillations in the Basal Ganglia
title_full_unstemmed The Role of Inhibition in Generating and Controlling Parkinson’s Disease Oscillations in the Basal Ganglia
title_short The Role of Inhibition in Generating and Controlling Parkinson’s Disease Oscillations in the Basal Ganglia
title_sort role of inhibition in generating and controlling parkinson’s disease oscillations in the basal ganglia
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3199726/
https://www.ncbi.nlm.nih.gov/pubmed/22028684
http://dx.doi.org/10.3389/fnsys.2011.00086
work_keys_str_mv AT kumararvind theroleofinhibitioningeneratingandcontrollingparkinsonsdiseaseoscillationsinthebasalganglia
AT cardanobilestefano theroleofinhibitioningeneratingandcontrollingparkinsonsdiseaseoscillationsinthebasalganglia
AT rotterstefan theroleofinhibitioningeneratingandcontrollingparkinsonsdiseaseoscillationsinthebasalganglia
AT aertsenad theroleofinhibitioningeneratingandcontrollingparkinsonsdiseaseoscillationsinthebasalganglia
AT kumararvind roleofinhibitioningeneratingandcontrollingparkinsonsdiseaseoscillationsinthebasalganglia
AT cardanobilestefano roleofinhibitioningeneratingandcontrollingparkinsonsdiseaseoscillationsinthebasalganglia
AT rotterstefan roleofinhibitioningeneratingandcontrollingparkinsonsdiseaseoscillationsinthebasalganglia
AT aertsenad roleofinhibitioningeneratingandcontrollingparkinsonsdiseaseoscillationsinthebasalganglia